TIRAP Ser180Leu polymorphism is associated with Behçet's disease

Rheumatology

Volumn 50, Issue 10, 2011, Pages 1760-1765

  Durrani, Omar ^a   Banahan, Katherine ^b   Sheedy, Frederick J ^b   McBride, Laura ^c   Ben Chetrit, Eldad ^d   Greiner, Kathryn ^e   Vaughan, Robert W ^c   Kondeatis, Elli ^c   Hamburger, John ^a   Fortune, Farida ^f   Stanford, Miles R ^c   Murray, Philip I ^a   O'Neill, Luke A ^b   Wallace, Graham R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e St John Eye Hospital   (Israel)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Be het; s disease; Gene polymorphisms; Infection; Inflammation; Toll like receptors; Toll interleukin receptor 1 domain containing adaptor protein

Indexed keywords

CD14 ANTIGEN; LEUCINE; PROTEIN; SERINE; TIRAP PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ARTICLE; BEHCET DISEASE; CHEEK MUCOSA; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LICHEN PLANUS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYOGENIC GRANULOMA; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

ANTIGENS, CD14; BEHCET SYNDROME; DNA; GRANULOMA, PYOGENIC; HUMANS; LEUCINE; LICHEN PLANUS; MEMBRANE GLYCOPROTEINS; MOUTH MUCOSA; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-1; SERINE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 80053134880     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker200     Document Type: Article

References (28)

1. Deuter CM, Kotter I, Wallace GR, Murray PI, Stubinger N, Zierhut M. Behçet's disease: ocular effects and treatment. Prog Retin Eye Res 2008;27:111-36.
2. Alpsoy E. Beçhet's disease: treatment of mucocutaneous ulcers. Clin Exp Rheumatol 2005;23:532-9.
3. Isogai E, Ohno S, Kotake S et al. Chemiluminescence of neutrophils from patients with Behçet's disease and its correlation with an increased proportion of uncommon serotypes of Streptococcus sanguis in the oral flora. Arch Oral Biol 1990;35:43-8.
4. Hamzaoui K, Kahan A, Ayed K, Hamza M. Cytotoxic T cells against herpes viruses in patients with Behçet's disease. Clin Exp Immunol 1990;81:390-5.
5. Pervin K, Childerstone A, Shinnick T et al. T cell epitope expression of mycobacterial and homologous human 65 kilodalton heat shock protein peptides in short term cell lines from patients with Behcet's disease. J Immunol 1993;151:2273-82.
6. Misch EA, Hawn TR. Toll-like receptor polymorphisms and susceptibility to human disease. Clin Sci 2008;114: 347-60.
7. Yavuz S, Elbir Y, Tulunay A, Eksioglu-Demiralp E. Direskeneli H. Differential expression of Toll-like receptor on granulocytes and monocytes implicates the role of microorganisms in Behçet's disease etiopathogenesis. Rheumatol Int 2008;28:401-6.
8. Do JE, Kwon SY, Park S, Lee ES. Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behçet's disease. Rheumatology 2008;47: 840-8.
9. Lorenz E, Mira JP, Cornish KL, Arbour NC. Schwartz DA. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000;68:6398-401.
10. Kang TJ, Lee SB, Chae GT. A polymorphism in the Toll-like receptor 2 is associated with decreased IL-12 production from monocytes in lepromatous leprosy. Cytokine 2002;20:56-62.
11. Smirnova I, Hamblin MT, McBride C, Beutler B, Di Renzo A. Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans. Genomics 2001;158: 1657-64.
12. Agnese DM, Calvano JC, Hahm SJ et al. Human Toll-like receptor 4 mutations, but not CD14 polymorphisms are associated with an increased risk of Gram-negative infections. J Infect Dis 2002;186:1522-5.
13. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients withGram-negative septic shock. Arch Intern Med 2002;162: 1028-32.
14. Sutherland AM, Walley KR, Russell JA. Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med 2005;33:638-44.
15. Khor CC, Chapman SJ, Vannberg FO et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteraemia, malaria and tuberculosis. Nat Genet 2007;39:523-8.
16. Castiblanco J, Varela DC, Castano-Rodriguez N, Rojas-Villarraga A, Hincapie ME, Anaya JM. TIRAP (Mal) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus. Infect Genet Evol 2008;8:541-4.
17. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078.
18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
19. Dalghous AM, Freysdottir J, Fortune F. Expression of cytokines, chemokines and chemokine receptors in oral ulcers of patients with Behçet's disease(BD) and recurrent aphthous stomatitis is Th1 mediated, although Th2-association is also observed in patients with BD. Scand J Rhuematol 2006;35:472-5.
20. Kose O, Stewart J, Waseem A, Lalli A, Fortune F. Expression of cytokeratins, adhesion and activation molecules in oral ulcers of Behcet's disease. Clin Exp Dermatol 2008;33:62-9.
21. Banks I, Duvdevani M, Livneh A. Expansion of gd T cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers. J Lab Clin Med 2003;141: 33-40.
22. Villaroel Dorrego M, Correnti M, Delgado R, Tapia FJ. Oral lichen planus: immunohistology of mucosal lesions. J Oral Pathol Med 2002;31:410-4.
23. Sugerman PB, Savage NW, Walsh LJ et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002; 13:350-65.
24. Bacanli A, Sallakci N, Yavuzer U, Alpsoy E. Yegin O. Toll-like receptor 2 Arg753Gln gene polymorphism in Turkish patients with Behçet's disease. Clin Exp Dermatol 2006;31:699-701.
25. Ito A, Ota M, Katsuyama Y, Inoko H, Ohno S, Mizuki N. Lack of association of Toll-like receptor 9 gene polymorphism with Behçet's disease in Japanese patients. Tiss Ags 2007;70:423-6.
26. Meguro A, Ota M, Katsuyama Y et al. Association of the toll-like receptor 4 gene polymorphisms with Behcet's disease. Ann Rheum Dis 2008;67:725-6.
27. Ferwerda B, McCall MB, Alonso S et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci USA 2007;104:16645-50.
28. Ferwerda B, Alonso S, Banahan K et al. Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock. Proc Natl Acad Sci USA 2009;106: 10272-7.